Managing side effects of CML treatments
Download
Report
Transcript Managing side effects of CML treatments
Peig Carroll
CML Nurse Specialist
St. James’s Hospital
Dublin
To review the common side effects of the
Tyrosine Kinase Inhibitors (TKI’s) that are
currently used in the treatment of CML
To increase awareness of some of the
different side effect profiles of each one
To offer practical advice on how to manage
the non- haematological side effects
Most patients with Chronic Myeloid
Leukaemia will require life long treatment in
the form of a Tyrosine Kinase Inhibitor (TKI)
Strict medication adherence is required to
achieve and maintain a good response to
treatment
Reduction and management of side effects
from TKIs is essential for quality of life
Nilotinib (Tasigna)
Imatinib (Glivec)
Diarrhoea
Constipation
Vomiting
Arthralgias (joint
aches/pains)
Cough
Rash
Pruritis (itching)
Nausea
Headache
Fatigue
Oedema (fluid
retention)
Nausea/
indigestion
Muscle cramps
Musculoskeletal
pain
Diarrhoea
Rash
Fatigue
Headache
Abdominal pain
Dasatinib (Sprycel)
Diarrhoea
Headache
Cough
Skin rash
Fever
Nausea/Indigestion
Fatigue
Muscle pain
Infections
Swelling of eyelids very common with Imatinib
Mild diuretic, reduce salt intake, maintain
hydration
Dry Eyes - Lacrilube (lubricating gel) apply at
night, Artificial tears, apply anytime
Subconjunctival Haemorrhage (Blood shot eye)
Unsightly but not dangerous. Clear-eye drops
More common in the first few weeks of taking TKIs
Reduced by taking Imatinib (Glivec) after a meal,
may help to divide dose to twice a day
Nilotinib (Tasigna) on an empty stomach, 2 hours
after and 1 hour before food
Dasatinib can be taken with or without food, dose
should not be divided
Anti-nausea drugs available if necessary,
Metoclopramide, (Maxolon) all 3 TKIs
Take 1 hour before dose
If history of indigestion or heartburn - breath test to
check for presence of Helicobacter Pylori infection
If present treat with antibiotics and proton pump
inhibitor
Imatinib and Nilotinib, Omeprazole (Losec) or
Lansoprazole (Zoton)
Dasatinib - H2 blockers or proton pump inhibitors
not recommended. If required should be taken 12
hours apart
Can occur with all 3 TKIs
Topical hydrocortisone creams
Antihistamines particularly if itchy
If rash is severe drug should be held and oral
Prednisone given. TKI should be restarted at
lower dose and increased on weekly basis to full
dose if tolerated
Mild red pimply type rash, low dose antibiotic
Dry Skin - use daily moisturiser
Maintain adequate daily fluid intake
Increased Photo Sensitivity (burn from sun more
easily)
Avoid direct sunlight – always wear high factor
sun screen and a hat
Leg Cramps – Calcium and Magnesium supplement
(CAL-MAG) taken daily
Musculoskeletal pain – Paracetamol in small
amounts - no more than 2 grams per day
Ibuprofen non-steroidal anti inflammatory (NSAI)
can cause stomach upset/pain
Heat packs -Topical anti-inflammatory gels/creams
Gentle non-weight bearing exercise
Interferes with the person’s ability to carry out
ordinary daily activities and it is not relieved by
rest or sleep
Reduced activity and exercise causes aches and
pains, weakened muscles and fitness
Fatigue can result in avoiding activity
This in turn can cause emotions of Frustration,
Anxiety, Sadness, leading to further fatigue
Regular exercise improves energy and mood
Set realistic goals, begin slowly and increase
workouts gradually
Get plenty of sleep and try to reduce stress
Cognitive behavioural therapy, Yoga and meditation
increase feelings of wellbeing
Eat foods high in energy, keep hydrated
Diarrhoea common with high dose Imatinib
Less common with Nilotinib or Dasatinib
Eat foods like pasta, rice or bread, which are high
in carbohydrates
Keep hydrated, maintain fluid intake - 2 liters per
day
Anti-diarrhoeal medicine, Loperamide
More common with Nilotinib and Dasatinib
Increase fibre intake, eat more fruit, wholegrain
bread and cereal, vegetables
Increase fluid intake
20 – 30 minutes gentle exercise per day
If required stool softners, lactulose and mild
laxative, senokot
Pleural effusions [fluid on the lung] appear to be a unique
side effect of Dasatinib
Symptoms suggestive of pleural effusion include
shortness of breath, dry cough, chest pain
Chest x-rays should be undertaken to confirm diagnosis
To relieve symptoms a low dose diuretic (fluid tablet)
should be used.
More severe cases may need fluid drained or
prednisolone
All TKIs are metabolised (broken down) in the liver and
kidneys
Nilotinib (Tasigna) is associated with elevated lipase and
bilirubin (pancreatic enzyme used for breaking down fats);
hyperglycaemia (increased blood sugar level);
Imatinib (Glivec) is associated with hypophosphataemia,
(low phosphate); hypokalemia (low calcium) in a
proportion of patients – Calcium supplements sometimes
advised
Blood Glucose and Renal Liver Bone tests should be
carried out regularly to monitor any changes
Side effects can vary from patient to patient and
can be mild to severe regardless of age
Careful consideration should be given to each
patient’s medical history when choosing a TKI
Choice of second-line treatment should involve
consideration of patients previous side-effect profile
Do not always assume that symptoms are related
to side effect of medication. Seek medical advice if
symptoms arise suddenly or become severe